{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:37:08Z","timestamp":1790203028743,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bbr.2013.06.019","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T15:16:24Z","timestamp":1371309384000},"page":"302-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE)"],"prefix":"10.1016","volume":"252","author":[{"given":"Curtis A.","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Tenorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9648","key":"10.1016\/j.bbr.2013.06.019_bib0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.bbr.2013.06.019_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02464784","article-title":"Changes in neurotransmitters in multiple sclerosis","volume":"28","author":"Barkhatova","year":"1998","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"12","key":"10.1016\/j.bbr.2013.06.019_bib0015","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2362.1997.2250774.x","article-title":"Neurotransmitters in cerebrospinal fluid reflect pathological activity","volume":"27","author":"Stover","year":"1997","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.bbr.2013.06.019_bib0020","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1471-4159.1983.tb08156.x","article-title":"Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis","volume":"40","author":"White","year":"1983","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2011.03.020","article-title":"Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE)","volume":"59","author":"Musgrave","year":"2011","journal-title":"Neurochemistry International"},{"issue":"1-2","key":"10.1016\/j.bbr.2013.06.019_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.07.013","article-title":"Dopamine by itself activates either D2, D3 or D1\/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both","volume":"169","author":"Besser","year":"2005","journal-title":"Journal of Neuroimmunology"},{"issue":"6","key":"10.1016\/j.bbr.2013.06.019_bib0035","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1-2","key":"10.1016\/j.bbr.2013.06.019_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2007.05.021","article-title":"Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients","volume":"188","author":"Sarchielli","year":"2007","journal-title":"Journal of Neuroimmunology"},{"issue":"1-2","key":"10.1016\/j.bbr.2013.06.019_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2006.08.004","article-title":"5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes","volume":"181","author":"Yin","year":"2006","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"10.1016\/j.bbr.2013.06.019_bib0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.coph.2008.05.001","article-title":"Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors","volume":"8","author":"Levite","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2249.2005.02901.x","article-title":"Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE","volume":"142","author":"Hofstetter","year":"2005","journal-title":"Clinical and Experimental Immunology"},{"issue":"2","key":"10.1016\/j.bbr.2013.06.019_bib0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11481-009-9182-2","article-title":"Increasing CNS noradrenaline reduces EAE severity","volume":"5","author":"Simonini","year":"2010","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1-2","key":"10.1016\/j.bbr.2013.06.019_bib0065","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2008.11.002","article-title":"Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE)","volume":"141","author":"Olechowski","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbr.2011.01.018","article-title":"Inflammation modulates anxiety in an animal model of multiple sclerosis","volume":"220","author":"Peruga","year":"2011","journal-title":"Behavioural Brain Research"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0889-1591(02)00010-7","article-title":"Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of \u2018depression due to multiple sclerosis\u2019","volume":"16","author":"Pollak","year":"2002","journal-title":"Brain, Behavior, and Immunity"},{"issue":"Pt. 3","key":"10.1016\/j.bbr.2013.06.019_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awq362","article-title":"Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"134","author":"Polak","year":"2011","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.bbr.2013.06.019_bib0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015908785777193","article-title":"Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function. Part II. Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans","volume":"6","author":"Samuels","year":"2008","journal-title":"Current Neuropharmacology"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2013.06.019_bib0090","first-page":"21","article-title":"The role of GABA in anxiety disorders","volume":"64","author":"Lydiard","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2013.06.019_bib0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0006-2952(00)00244-6","article-title":"Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant\/antipanic drug phenelzine","volume":"59","author":"Parent","year":"2000","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bbr.2013.06.019_bib0100","series-title":"MAOI Therapy of Social Phobia, in Progress in Psychiatry","first-page":"225","author":"Gitow","year":"1994"},{"key":"10.1016\/j.bbr.2013.06.019_bib0105","series-title":"MAOIs in Panic Disorder and Agoraphobia, in Progress in Psychiatry","first-page":"205","author":"Johnson","year":"1994"},{"key":"10.1016\/j.bbr.2013.06.019_bib0110","series-title":"Kaplan & Sadock's Comprehensive Textbook of Psychiatry","first-page":"3154","article-title":"Monoamine oxidase inhibitors","author":"Kennedy","year":"2009"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2006.09.003","article-title":"Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine","volume":"1122","author":"Wood","year":"2006","journal-title":"Brain Research"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-2952(69)90105-1","article-title":"The monoamine oxidase catalyzed degradation of phenelzine-l-14C: an irreversible inhibitor of monoamine oxidase--II. Studies in vivo","volume":"18","author":"Clineschmidt","year":"1969","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0006-2952(69)90104-X","article-title":"The monoamine oxidase catalyzed degradation of phenelzine-l-14C: an irreversible inhibitor of monoamine oxidase--I. Studies in vitro","volume":"18","author":"Clineschmidt","year":"1969","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2013.06.019_bib0130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.1969.tb08978.x","article-title":"Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain","volume":"16","author":"Popov","year":"1969","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2013.06.019_bib0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10177833.2010.11790656","article-title":"Phenelzine: an old drug that may hold clues to the development of new neuroprotective agents","volume":"20","author":"MacKenzie","year":"2010","journal-title":"Bulletin of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0140","first-page":"313","article-title":"Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?","volume":"32","author":"Baker","year":"2007","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1016\/j.bbr.2013.06.019_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ddr.1202","article-title":"Beta-Phenylethylidenehydrazine, a novel inhibitor of GABA transaminase","volume":"54","author":"Paslawski","year":"2001","journal-title":"Drug Development Research"},{"key":"10.1016\/j.bbr.2013.06.019_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2011.06.011","article-title":"The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)","author":"Musgrave","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"10.1016\/j.bbr.2013.06.019_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0327(95)00056-9","article-title":"GABA-elevating effects of the antidepressant\/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (\u2212)-deprenyl and clorgyline","volume":"35","author":"Todd","year":"1995","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.bbr.2013.06.019_bib0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MJT.0b013e31825b9eb5","article-title":"Monoamine oxidase inhibitors and neuroprotection: a review","volume":"19","author":"Al-Nuaimi","year":"2012","journal-title":"American Journal of Therapeutics"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0165","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00169549","article-title":"N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines","volume":"343","author":"McKenna","year":"1991","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2009.10.003","article-title":"5-HT precursor loading: but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats","volume":"221","author":"Hayashi","year":"2010","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/j.bbr.2013.06.019_bib0175","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1152\/jappl.2000.89.4.1528","article-title":"5-Hydroxytryptophan-induced respiratory recovery after cervical spinal cord hemisection in rats","volume":"89","author":"Zhou","year":"2000","journal-title":"Journal of Applied Physiology"},{"issue":"1","key":"10.1016\/j.bbr.2013.06.019_bib0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1471-4159.2008.05750.x","article-title":"Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis","volume":"108","author":"Markianos","year":"2009","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.bbr.2013.06.019_bib0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00075197-200303000-00013","article-title":"l-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent","volume":"6","author":"Zhong","year":"2003","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"11","key":"10.1016\/j.bbr.2013.06.019_bib0190","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/jnr.22395","article-title":"The inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters","volume":"88","author":"Carmans","year":"2010","journal-title":"Journal of Neuroscience Research"},{"issue":"18","key":"10.1016\/j.bbr.2013.06.019_bib0195","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/sj.emboj.7601840","article-title":"D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis","volume":"26","author":"Sasabe","year":"2007","journal-title":"The EMBO Journal"},{"issue":"7","key":"10.1016\/j.bbr.2013.06.019_bib0200","first-page":"507","article-title":"Will the real multiple sclerosis please stand up? Nature reviews","volume":"13","author":"Stys","year":"2012","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.bbr.2013.06.019_bib0205","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/mnfr.201100217","article-title":"Acrolein-mediated injury in nervous system trauma and diseases","volume":"55","author":"Shi","year":"2011","journal-title":"Molecular Nutrition & Food Research"},{"issue":"8","key":"10.1016\/j.bbr.2013.06.019_bib0210","doi-asserted-by":"crossref","first-page":"e42959","DOI":"10.1371\/journal.pone.0042959","article-title":"Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes","volume":"7","author":"Mendu","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bbr.2013.06.019_bib0215","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/intimm\/dxh242","article-title":"5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes","volume":"17","author":"Durk","year":"2005","journal-title":"International Immunology"},{"issue":"3","key":"10.1016\/j.bbr.2013.06.019_bib0220","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbi.2010.10.019","article-title":"Epigenetic regulation of beta2-adrenergic receptor expression in T(H)1 and T(H)2 cells","volume":"25","author":"McAlees","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.bbr.2013.06.019_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","article-title":"The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?","volume":"26","author":"Sanders","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1-2","key":"10.1016\/j.bbr.2013.06.019_bib0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","article-title":"Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study","volume":"132","author":"McKenna","year":"2002","journal-title":"Journal of Neuroimmunology"},{"issue":"8","key":"10.1016\/j.bbr.2013.06.019_bib0235","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.4049\/jimmunol.173.8.4821","article-title":"Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A","volume":"173","author":"Chaitidis","year":"2004","journal-title":"Journal of Immunology"},{"issue":"2.","key":"10.1016\/j.bbr.2013.06.019_bib0240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jchromb.2006.07.022","article-title":"Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection","volume":"884","author":"Grant","year":"2006","journal-title":"Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T12:37:48Z","timestamp":1715517468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":48,"alternative-id":["S0166432813003744"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.06.019","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE)","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}